Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:35 AM
Ignite Modification Date: 2025-12-25 @ 2:35 AM
NCT ID: NCT06784934
Eligibility Criteria: Inclusion Criteria: * Aged between 18 and 30 years old * Currently enrolled in a 4-year university * Individuals from an ethnic or racial minority background (i.e., "The minority racial and ethnic groups defined by Office of Management and Budget's (OMB) are American Indian or Alaska Native, Asian, Black or African American, and Native Hawaiian or Pacific Islander. The ethnicity used is Latino or Hispanic.") Exclusion Criteria: * Severe depression (cut off score of 15 or higher on Patient Health Questionnaire 9 (PHQ-9)) * Previously receiving biofeedback training. * Severe medical condition (e.g., pacemaker, cardiac arrhythmia, hypertension, diabetes). * Showing symptoms of psychosis * Having a neurological condition (e.g., Parkinson's disease) that would complicate the interpretation of physiological data. * Taking medications such as SSRIs, alpha/beta-blockers, or withdrawal or maintenance medications (e.g., Librium, methadone) * Using substances such as tobacco and illicit drugs, and 8)alcohol consumption as defined by National Institute of Health (NIH) as "more than 2 drinks (1 drink for women) in a day or drinking more than 5 drinks (4 for women) on the same occasion (i.e., at the same time or within a couple of hours of each other) on at least 1 day in the past month" are excluded due to their potential to affect the data.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 30 Years
Study: NCT06784934
Study Brief:
Protocol Section: NCT06784934